Acceptance and Commitment Group Therapy (ACT) for Patients With Health Anxiety

Hypochondriasis Clinical Trial

— ACT  

Official title:

Treatment of Patients With Health Anxiety. A Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) Group Treatment Compared to a Waiting List

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01158430
• Other study ID #: 2001001
• Status: Completed
• Phase: N/A
• First received: February 16, 2010
• Last updated: April 12, 2013
• Start date: March 2010
• Est. completion date: April 2013

Study information

• Verified date: April 2013
• Source: University of Aarhus
• Contact: n/a
• Is FDA regulated: No
• Health authority: Denmark: The Regional Committee on Biomedical Research Ethics
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine the effect of Acceptance and Commitment Therapy (ACT) in groups on functional level, emotional problems, and use of health care in patients with severe health anxiety in a randomized, controlled design.

Description:

Health anxiety disorder or Hypochondriasis is a prevalent somatoform disorder, but a rarely used diagnosis in clinical practice despite studies having reported prevalence between 0.8-9.5% in primary care (Fink et al, 2004). As a consequence, the disorder is rarely treated.

The lack of valid, reliable, and generally accepted diagnostic criteria has been a major obstacle in clinical practice and Hypochondriasis studies, which causes problems particularly in distinguishing Hypochondriasis patients from other patients presenting with medically unexplained symptoms or functional symptoms.

In 2004, the investigators introduced a radically revised definition of Hypochondriasis. Hypochondriasis is viewed as a stigmatizing label, and the designation health anxiety has been suggested as replacement. This new diagnosis is empirically established. The essential feature of health anxiety is that the patients present with cognitive symptoms such as unfounded worrying about their health. In contrast to other somatoform disorders, the patients are not necessarily plagued by physical symptoms.

The new diagnostic criteria include the symptom 'obsessive rumination about illness' plus at least one of the symptoms 'worry or preoccupation with fears of harboring an illness or with bodily functions', 'suggestibility or autosuggestibility', 'an unrealistic fear of being infected or contaminated', 'an excessive fascination with medical information', or 'fear of taking prescribed medication'.

In the current study, health anxiety is diagnosed by use of newly introduced empirically established positive criteria for Health anxiety (Fink et al, 2004).

Most patients with health anxiety disorder receive the majority of their care in primary care settings. They are often unhappy with the services they receive, and primary care providers often feel unprepared to address symptoms that primarily appear functional.

During the past 5 years, the investigators have treated patients suffering from severe functional disorder (i.e. Bodily distress syndrome or Somatization disorder) in randomized controlled trials (RCTs) - at the Research Clinic. The investigators reject many patients suffering from health anxiety, who have no other treatment opportunities, and there is an impending need for treatment opportunities. The investigators research group has done research in epidemiology, psychopathology and diagnostics of Health anxiety, and the investigators are part of international networks regarding the revision of the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders V (DSM-V) and the International Classification of Diseases 11 (ICD-11).

RCTs have shown that Cognitive Behavioral Therapy (CBT) has effect on health anxiety (Barsky & Ahern, 2004; Greeven et al., 2007), and one of the trials also showed effect of anti-depressant medication (Greeven et al., 2007).

In general, the treatment of health anxiety is sparsely investigated both as to psychotherapy and medical treatment.

The investigators wish to examine the effect of Acceptance and Commitment Therapy (ACT) in groups on functional level, emotional problems, and use of health care in patients with severe health anxiety in a randomized, controlled design.

Health anxiety disorder is a burden for the sufferers and costly for society due to lost working years because of early onset of the disorder and high health care costs. The development of evidence-based treatment offering these patients the same professional treatment as patients with other disorders may lead to better quality of life for the patients and reduction in health care costs.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 126
• Est. completion date: April 2013
• Est. primary completion date: April 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 20 Years to 60 Years

Eligibility

Inclusion Criteria:

1. Whiteley-7 score on 21,4 or more (scale 0-100 score points).

2. Severe health anxiety (diagnosed by SCAN interview).

3. Age 20-60 years

4. Patients of Scandinavian origin who understand, read, write and speak Danish.

5. No lifetime-diagnosis of psychoses, bipolar affective disorder or depression with psychotic symptoms (ICD-10: F20-29, F30-31, F32.3, F33.3)

6. In case of a co morbid functional or other psychiatric disorder health anxiety must be the dominating problem.

Exclusion criteria:

1. Another severe psychiatric disorder or if the patient is suicidal.

2. Abuse of narcotics or alcohol and (non-prescribed) medicine.

3. Pregnancy.

4. No informed consent.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Hypochondriasis
• Somatization Disorder
• Somatoform Disorders

Intervention

Behavioral:
• ACT group therapy
Group therapy (ACT) in groups of 9 patients in 9 weekly 3.5-hours sessions & 1 booster session 1 month after 9th session, a total of 35.5 hours

Locations

Country	Name	City	State
Denmark	The Research Clinic for Functional Disorders, Aarhus University Hospital	Aarhus C

Sponsors (1)

Lead Sponsor	Collaborator
University of Aarhus

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Health anxiety measured by the Whiteley-7 index		9 months (2nd follow-up)	No
Secondary	Social level of functioning measured with Short Form health status questionnaire from the medical outcome status (SF-36)		9 months (2nd follow-up)	No
Secondary	Social level of functioning, emotional disorders measured with relevant sub-scales from Symptom Check List, 90 items (SCL 90)		9 months (2nd follow-up)	No
Secondary	Social level of functioning measured with an alcohol dependency questionnaire (CAGE)		9 months (2nd follow-up)	No
Secondary	Illness perception measured with Illness Perception Questionnaire (IPQ)		9 months (2nd follow-up)	No
Secondary	Physical symptoms measured with somatisation subscales from Symptom Check List, 90 items (SCL 90)		9 months (2nd follow-up)	No
Secondary	Health care use (National Patient Register & National Health Service Register (general practitioner (GP) contacts/consultations, specialists, physiotherapists, dentists, GPs' emergency service), The Danish Medicine Agency (medicine consumption)).		9 months (2nd follow-up)	No
Secondary	Sick days (the DREAM database - the register-based evaluation of the extent of marginalization)		9 months (2nd follow-up)	No
Secondary	ACT process measures measured with Five Facet Mindfulness Questionnaire (FFMQ)		9 months (2nd follow-up)	No
Secondary	ACT process measures measured with Acceptance and Action Questionnaire - II (AAQ II)		9 months (2nd follow-up)	No

External Links

•   Link